PHSSR Policy Roadmaps for Acting Early on NCDs Synthesis Report 2025

110 Acting early on NCDs The Partnership for Health System Sustainability and ResilienceFontbonne, A., Currie, A., Tounian, P ., Picot, M.-C., Foulatier, O., Nedelcu, M., Nocca, D. (2023). Prevalence of Overweight and Obesity in France: The 2020 Obepi-Roche Study by the “Ligue Contre l’Obésité". Journal of Clinical Medicine , 12(3), 925. Francis-Oliviero, F., Constantinou, P ., Haneef, R., Schwarzinger, M., Gallay, A., Rachas, A., Alla, F. (2024). The health state of France before COVID-19 pandemic between 1990 and 2019: An analysis of the Global Burden of Disease study 2019. The Lancet Regional Health – Europe , 39, 100848. G G-BA (Gemeinsamer Bundesausschuss). (2025). Disease-Management-Programme. Available at: www.g-ba.de/themen/disease-management-programme Gaudette, É., Rizzardo, S., Pothier, K.R., Tadrous, M. (2025). Factors delaying the public listing of drugs in Canada. Ottawa: Patented Medicine Prices Review Board. Gitt, A. K., et al. (2016). Better lipid target achievement for secondary prevention through disease management programs for diabetes mellitus and coronary heart disease in clinical practice in Germany. Current Medical Research and Opinion , 32(3), 417–426. GKV-Spitzenverband. (2025). Digitale Gesundheitsanwendungen (DiGA). Available at: www.gkv-spitzenverband.de/krankenversicherung/digitalisierung/kv_diga/diga.jsp Glennie, J., Gesy, K., Nguyen, Y. (2023). Canadian public payer best practices for providing timely patient access to cancer therapies. Canadian Health Policy . Global Initiative for Chronic Obstructive Lung Disease (GOLD). (2024). Global Strategy for the Diagnosis, Management, and Prevention of COPD. Available at: https://goldcopd.org Gobierno Vasco. (2010). Estrategia para afrontar el reto de la cronicidad en Euskadi. Vitoria-Gasteiz: Departamento de Sanidad y Consumo. Government of Canada. (2024). Canadian Chronic Disease Surveillance System (CCDSS). Available at: https://health-infobase.canada.ca/ccdss/Index Government of Canada. (2025). Government of Canada’s approach on Gender-based Analysis Plus. Available at: www.canada.ca/en/women-gender-equality/gender-based-analysis-plus/government- approach.html Government of Canada. (n.d.). Diabetes: What Canada’s doing. Ottawa: Government of Canada. Government Gazette. (2024). Issue 6443B/22-11-2024. Athens: National Printing Office. Grea, C., Busl, L., Dittmann, A., Ehnle-Lossos, M., Elflein-Mack, A., Goos, E., Kondula, V., Werner, R., Wolff, D., Roser, S., & Storcksdieck genannt Bonsmann, S. (2024). Produktmonitoring 2023: Ergebnisbericht. H HAS. (2020a). Maladies chroniques dans le cadre de la Covid-19. Haute Autorité de Santé. Available at: www.has-sante.fr/jcms/p_3178526/fr/maladies-chroniques-dans-le-cadre-de-la-covid-19 HAS. (2020b). Stratégie de vaccination contre le Sars-Cov-2 – Recommandations préliminaires sur la stratégie de priorisation des populations à vacciner. Available at: https://www.has-sante.fr/jcms/ p_3221338/fr/strategie-de-vaccination-contre-le-sars-cov-2-recommandations-preliminaires-sur-la- strategie-de-priorisation-des-populations-a-vacciner